Abstract
People deny health risks, invest too little in disease prevention, and are highly sensitive to the price of preventative health care, especially in developing countries. Moreover, private sector R&D spending on developing-country diseases is almost non-existent. To explain these empirical observations, I propose a model of motivated belief formation, in which an agent's decision to engage in health risk denial balances the psychological benefits of reduced anxiety with the physical cost of underprevention. I use the model to study firms' price-setting behavior and incentive to innovate. I also show that tax-funded prevention subsidies are welfare enhancing. (C) 2019 Elsevier B.V. All rights reserved.
| Item Type: | Journal article |
|---|---|
| Faculties: | Economics |
| Subjects: | 300 Social sciences > 330 Economics |
| ISSN: | 0167-6296 |
| Language: | English |
| Item ID: | 78288 |
| Date Deposited: | 15. Dec 2021 14:43 |
| Last Modified: | 15. Dec 2021 14:43 |
